Nikkei Asia | The Quad should have its own biomanufacturing hub in India

Biomanufacturing, which uses microorganisms and cell cultures to produce molecules and materials on a large scale, is rapidly rising in importance for Indo-Pacific nations. The world's response to COVID-19 depended on the rapid production of new vaccines through biomanufacturing. Countries with preexisting manufacturing capabilities became the gatekeepers of vaccine supply. Scaling up biomanufacturing in India will be fraught with challenges, however, but these can be overcome with external support. The Quad group in particular is ideally placed to collaborate and boost India's efforts.

Read more here